PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $122,000 | -13.5% | 38,671 | -20.4% | 0.00% | – |
| Q2 2020 | $141,000 | +6.8% | 48,591 | +3.4% | 0.00% | – |
| Q1 2020 | $132,000 | -18.0% | 47,008 | -5.4% | 0.00% | – |
| Q4 2019 | $161,000 | -30.0% | 49,716 | -53.4% | 0.00% | – |
| Q3 2019 | $230,000 | -78.9% | 106,630 | -69.3% | 0.00% | – |
| Q2 2019 | $1,092,000 | -76.6% | 347,638 | -72.2% | 0.00% | -100.0% |
| Q1 2019 | $4,658,000 | +469.4% | 1,252,208 | +343.4% | 0.00% | – |
| Q4 2018 | $818,000 | +240.8% | 282,404 | +209.2% | 0.00% | – |
| Q3 2018 | $240,000 | -87.5% | 91,325 | -88.8% | 0.00% | – |
| Q2 2018 | $1,914,000 | +398.4% | 818,011 | +525.0% | 0.00% | – |
| Q1 2018 | $384,000 | -31.6% | 130,872 | -36.2% | 0.00% | – |
| Q4 2017 | $561,000 | +8.7% | 205,083 | +34.9% | 0.00% | – |
| Q3 2017 | $516,000 | -88.4% | 152,075 | -91.6% | 0.00% | -100.0% |
| Q2 2017 | $4,459,000 | +1267.8% | 1,805,182 | +1157.6% | 0.00% | – |
| Q1 2017 | $326,000 | +28.3% | 143,544 | +19.8% | 0.00% | – |
| Q4 2016 | $254,000 | -24.2% | 119,846 | +19.7% | 0.00% | – |
| Q3 2016 | $335,000 | -64.7% | 100,111 | -66.8% | 0.00% | – |
| Q2 2016 | $949,000 | -0.3% | 301,906 | +5.6% | 0.00% | – |
| Q1 2016 | $952,000 | -63.3% | 285,827 | -61.0% | 0.00% | – |
| Q4 2015 | $2,595,000 | -26.4% | 733,111 | +4.5% | 0.00% | -100.0% |
| Q3 2015 | $3,528,000 | -22.1% | 701,559 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $4,526,000 | -4.3% | 703,735 | +4.6% | 0.00% | 0.0% |
| Q1 2015 | $4,731,000 | -87.4% | 672,603 | -86.2% | 0.00% | -92.3% |
| Q4 2014 | $37,589,000 | +11.6% | 4,875,328 | +8.1% | 0.01% | +18.2% |
| Q3 2014 | $33,685,000 | +78.3% | 4,509,433 | +131.0% | 0.01% | +83.3% |
| Q2 2014 | $18,894,000 | -13.8% | 1,951,877 | -26.0% | 0.01% | -25.0% |
| Q1 2014 | $21,908,000 | -4.4% | 2,636,319 | -2.9% | 0.01% | 0.0% |
| Q4 2013 | $22,921,000 | -13.5% | 2,715,760 | -18.3% | 0.01% | -27.3% |
| Q3 2013 | $26,508,000 | +21.9% | 3,325,999 | +18.1% | 0.01% | +22.2% |
| Q2 2013 | $21,740,000 | – | 2,816,011 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |